When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DGX - FDA OKs expanded use of Oxford Immunotec TB test
Quest Diagnostics Incorporated
The FDA has cleared the use of Oxford Immunotec Global PLC's ([[OXFD]] +0.8%) T-SPOT.TB test in people as young as two years old. It was previously approved for use in people at least five years old.The test is available nationally through Quest Diagnostics ([[DGX]] -0.2%) and through regional laboratory partners.